Skip to main content
Top
Published in: Graefe's Archive for Clinical and Experimental Ophthalmology 10/2021

01-10-2021 | Color Vision Deficiency | Retinal Disorders

Evaluation of acquired color vision deficiency in retinal vein occlusion using the Rabin cone contrast test

Authors: Riko Matsumoto, Yoshitsugu Saishin, Masahito Ohji

Published in: Graefe's Archive for Clinical and Experimental Ophthalmology | Issue 10/2021

Login to get access

Abstract

Purpose

To investigate acquired color vision deficiency (CVD) using the Rabin cone contrast test (RCCT) in patients with retinal vein occlusion (RVO).

Methods

We retrospectively evaluated 39 patients with macular edema due to RVO who were treated with intravitreal injections of anti-VEGF agents and demonstrated improvement of best-corrected visual acuity to 20/20 Snellen VA or better. The acquired CVD was evaluated by the RCCT and standard pseudo-isochromatic plates-part 2 (SPP-2).

Results

Mean L, M, and S color contrast test (CCT) scores were significantly lower in RVO eyes than in the fellow eyes (L CCTs, 70.0 ± 13.3 vs. 90.0 ± 8.0, respectively, P < 0.01; M CCTs, 85.0 ± 16.6 vs. 95.0 ± 5.7, respectively, P < 0.01; S CCTs, 80.0 ± 21.5 vs. 95.0 ± 7.1, respectively, P < 0.01). Acquired CVD was diagnosed in 25 eyes of 39 patients by the RCCT and in 15 eyes of 39 patients by SPP-2. The RCCT was performed on two different days in 21 patients. It revealed acquired CVD in 17 eyes on the first day and in 10 eyes on the second day. Acquired CVD was improved in 9 eyes, unchanged in 8 eyes, and worsened in 2 eyes.

Conclusions

The RCCT revealed eyes with RVO had acquired CVD. Acquired CVD caused by RVO can be improved further in some cases even after recovery of vision to 20/20. The RCCT may be able to quantitatively diagnose acquired CVD status.
Literature
1.
go back to reference Rehak J, Rehak M (2008) Branch retinal vein occlusion: pathogenesis, visual prognosis, and treatment modalities. Curr Eye Res 33:111–131CrossRef Rehak J, Rehak M (2008) Branch retinal vein occlusion: pathogenesis, visual prognosis, and treatment modalities. Curr Eye Res 33:111–131CrossRef
2.
go back to reference Rogers SL, McIntosh RL, Lim L, Mitchell P, Cheung N, Kowalski JW, Nguyen HP, Wang JJ, Wong TY (2010) Natural history of branch retinal vein occlusion: an evidence-based systematic review. Ophthalmology 117:1094-1101 e1095CrossRef Rogers SL, McIntosh RL, Lim L, Mitchell P, Cheung N, Kowalski JW, Nguyen HP, Wang JJ, Wong TY (2010) Natural history of branch retinal vein occlusion: an evidence-based systematic review. Ophthalmology 117:1094-1101 e1095CrossRef
3.
go back to reference McIntosh RL, Mohamed Q, Saw SM, Wong TY (2007) Interventions for branch retinal vein occlusion: an evidence-based systematic review. Ophthalmology 114:835–854CrossRef McIntosh RL, Mohamed Q, Saw SM, Wong TY (2007) Interventions for branch retinal vein occlusion: an evidence-based systematic review. Ophthalmology 114:835–854CrossRef
4.
go back to reference Green WR, Chan CC, Hutchins GM, Terry JM (1981) Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases. Trans Am Ophthalmol Soc 79:371–422PubMedPubMedCentral Green WR, Chan CC, Hutchins GM, Terry JM (1981) Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases. Trans Am Ophthalmol Soc 79:371–422PubMedPubMedCentral
5.
go back to reference Campa C, Alivernini G, Bolletta E, Parodi MB, Perri P (2016) Anti-VEGF therapy for retinal vein occlusions. Curr Drug Targets 17:328–336CrossRef Campa C, Alivernini G, Bolletta E, Parodi MB, Perri P (2016) Anti-VEGF therapy for retinal vein occlusions. Curr Drug Targets 17:328–336CrossRef
6.
go back to reference Adams AJ (1982) Chromatic and luminosity processing in retinal disease. Am J Optom Physiol Opt 59:954–960CrossRef Adams AJ (1982) Chromatic and luminosity processing in retinal disease. Am J Optom Physiol Opt 59:954–960CrossRef
7.
go back to reference Greenstein VC, Hood DC, Ritch R, Steinberger D, Carr RE (1989) S (blue) cone pathway vulnerability in retinitis pigmentosa, diabetes and glaucoma. Invest Ophthalmol Vis Sci 30:1732–1737PubMed Greenstein VC, Hood DC, Ritch R, Steinberger D, Carr RE (1989) S (blue) cone pathway vulnerability in retinitis pigmentosa, diabetes and glaucoma. Invest Ophthalmol Vis Sci 30:1732–1737PubMed
8.
go back to reference O’Neill-Biba M, Sivaprasad S, Rodriguez-Carmona M, Wolf JE, Barbur JL (2010) Loss of chromatic sensitivity in AMD and diabetes: a comparative study. Ophthalmic Physiol Opt 30:705–716CrossRef O’Neill-Biba M, Sivaprasad S, Rodriguez-Carmona M, Wolf JE, Barbur JL (2010) Loss of chromatic sensitivity in AMD and diabetes: a comparative study. Ophthalmic Physiol Opt 30:705–716CrossRef
9.
go back to reference Feitosa-Santana C, Paramei GV, Nishi M, Gualtieri M, Costa MF, Ventura DF (2010) Color vision impairment in type 2 diabetes assessed by the D-15d test and the Cambridge Colour Test. Ophthalmic Physiol Opt 30:717–723CrossRef Feitosa-Santana C, Paramei GV, Nishi M, Gualtieri M, Costa MF, Ventura DF (2010) Color vision impairment in type 2 diabetes assessed by the D-15d test and the Cambridge Colour Test. Ophthalmic Physiol Opt 30:717–723CrossRef
10.
go back to reference Gella L, Raman R, Kulothungan V, Pal SS, Ganesan S, Srinivasan S, Sharma T (2017) Color vision abnormalities in type II diabetes: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetics Study II report no 2. Indian J Ophthalmol 65:989–994CrossRef Gella L, Raman R, Kulothungan V, Pal SS, Ganesan S, Srinivasan S, Sharma T (2017) Color vision abnormalities in type II diabetes: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetics Study II report no 2. Indian J Ophthalmol 65:989–994CrossRef
11.
go back to reference Maaranen TH, Tuppurainen KT, Mantyjarvi MI (2000) Color vision defects after central serous chorioretinopathy. Retina 20:633–637CrossRef Maaranen TH, Tuppurainen KT, Mantyjarvi MI (2000) Color vision defects after central serous chorioretinopathy. Retina 20:633–637CrossRef
12.
go back to reference Roy MS, Gunkel RD, Podgor MJ (1986) Color vision defects in early diabetic retinopathy. Arch Ophthalmol 104:225–228CrossRef Roy MS, Gunkel RD, Podgor MJ (1986) Color vision defects in early diabetic retinopathy. Arch Ophthalmol 104:225–228CrossRef
13.
go back to reference Okajima O, Tanino T, Okamoto M (1982) Color vision defects in pigmentary retinal dystrophy. Jpn J Ophthalmol 26:292–301PubMed Okajima O, Tanino T, Okamoto M (1982) Color vision defects in pigmentary retinal dystrophy. Jpn J Ophthalmol 26:292–301PubMed
14.
go back to reference François J, Verriest G (1961) On acquired deficiency of colour vision, with special reference to its detection and classification by means of the tests of Farnsworth. Vision Res 1:201–219CrossRef François J, Verriest G (1961) On acquired deficiency of colour vision, with special reference to its detection and classification by means of the tests of Farnsworth. Vision Res 1:201–219CrossRef
15.
go back to reference Cox J (1960) Colour vision defects acquired in diseases of the eye. Br J Physiol Opt 17:195–216PubMed Cox J (1960) Colour vision defects acquired in diseases of the eye. Br J Physiol Opt 17:195–216PubMed
16.
go back to reference Ogiso M (1993) Examination of confusion loci in acquired color vision deficiency with surface color. Nippon Ganka Gakkai Zasshi 97:411–418PubMed Ogiso M (1993) Examination of confusion loci in acquired color vision deficiency with surface color. Nippon Ganka Gakkai Zasshi 97:411–418PubMed
17.
go back to reference Rabin J (1996) Cone-specific measures of human color vision. Invest Ophthalmol Vis Sci 37:2771–2774PubMed Rabin J (1996) Cone-specific measures of human color vision. Invest Ophthalmol Vis Sci 37:2771–2774PubMed
18.
go back to reference Rabin J (2004) Quantification of color vision with cone contrast sensitivity. Vis Neurosci 21:483–485CrossRef Rabin J (2004) Quantification of color vision with cone contrast sensitivity. Vis Neurosci 21:483–485CrossRef
19.
go back to reference Rabin J, Gooch J, Ivan D (2011) Rapid quantification of color vision: the cone contrast test. Invest Ophthalmol Vis Sci 52:816–820CrossRef Rabin J, Gooch J, Ivan D (2011) Rapid quantification of color vision: the cone contrast test. Invest Ophthalmol Vis Sci 52:816–820CrossRef
20.
go back to reference Levin N, Devereux M, Bick A, Baker N, Green A (2019) Color perception impairment following optic neuritis and its association with retinal atrophy. J Neurol 266:1160–1166CrossRef Levin N, Devereux M, Bick A, Baker N, Green A (2019) Color perception impairment following optic neuritis and its association with retinal atrophy. J Neurol 266:1160–1166CrossRef
21.
go back to reference Niwa Y, Muraki S, Naito F, Minamikawa T, Ohji M (2014) Evaluation of acquired color vision deficiency in glaucoma using the Rabin cone contrast test. Invest Ophthalmol Vis Sci 55:6686–6690CrossRef Niwa Y, Muraki S, Naito F, Minamikawa T, Ohji M (2014) Evaluation of acquired color vision deficiency in glaucoma using the Rabin cone contrast test. Invest Ophthalmol Vis Sci 55:6686–6690CrossRef
22.
go back to reference Fujikawa M, Muraki S, Niwa Y, Ohji M (2018) Evaluation of clinical validity of the Rabin cone contrast test in normal phakic or pseudophakic eyes and severely dichromatic eyes. Acta Ophthalmol 96:e164–e167CrossRef Fujikawa M, Muraki S, Niwa Y, Ohji M (2018) Evaluation of clinical validity of the Rabin cone contrast test in normal phakic or pseudophakic eyes and severely dichromatic eyes. Acta Ophthalmol 96:e164–e167CrossRef
23.
go back to reference Tanabe SM, Koketsu K, Color H (1987) Vision test with’ standard pseudo-isochromatic plates part 2’ for ethambutol-induced optic neuropathy. Martinus Nijhoff Publishers, DordrechtCrossRef Tanabe SM, Koketsu K, Color H (1987) Vision test with’ standard pseudo-isochromatic plates part 2’ for ethambutol-induced optic neuropathy. Martinus Nijhoff Publishers, DordrechtCrossRef
24.
go back to reference Simunovic MP (2016) Acquired color vision deficiency. Surv Ophthalmol 61:132–155CrossRef Simunovic MP (2016) Acquired color vision deficiency. Surv Ophthalmol 61:132–155CrossRef
25.
go back to reference Honson VJ, Dain SJ (1988) Performance of the standard pseudoisochromatic plate test. Am J Optom Physiol Opt 65:561–570CrossRef Honson VJ, Dain SJ (1988) Performance of the standard pseudoisochromatic plate test. Am J Optom Physiol Opt 65:561–570CrossRef
26.
go back to reference Hovis JK, Cawker CL, Cranton D (1996) Comparison of the standard pseudoisochromatic plates–Parts 1 and 2–as screening tests for congenital red-green color vision deficiencies. J Am Optom Assoc 67:320–326PubMed Hovis JK, Cawker CL, Cranton D (1996) Comparison of the standard pseudoisochromatic plates–Parts 1 and 2–as screening tests for congenital red-green color vision deficiencies. J Am Optom Assoc 67:320–326PubMed
Metadata
Title
Evaluation of acquired color vision deficiency in retinal vein occlusion using the Rabin cone contrast test
Authors
Riko Matsumoto
Yoshitsugu Saishin
Masahito Ohji
Publication date
01-10-2021
Publisher
Springer Berlin Heidelberg
Published in
Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 10/2021
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-021-05171-7

Other articles of this Issue 10/2021

Graefe's Archive for Clinical and Experimental Ophthalmology 10/2021 Go to the issue